{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:30:11Z","timestamp":1761766211741,"version":"3.41.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jns.2017.06.011","type":"journal-article","created":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T00:31:44Z","timestamp":1497313904000},"page":"169-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Psychosis in Parkinson's disease: From the soft signs to the hard science"],"prefix":"10.1016","volume":"379","author":[{"given":"Abhishek","family":"Lenka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyantha","family":"Herath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramod Kumar","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2017.06.011_bb0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2017.06.011_bb0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1017\/S1092852900017284","article-title":"Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms","volume":"13","author":"F\u00e9nelon","year":"2008","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jns.2017.06.011_bb0015","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/mds.23835","article-title":"Visual plus nonvisual hallucinations in Parkinson's disease: development and evolution over 10years","volume":"26","author":"Goetz","year":"2011","journal-title":"Mov. Disord."},{"issue":"Pt 4","key":"10.1016\/j.jns.2017.06.011_bb0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors","volume":"123","author":"F\u00e9nelon","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jns.2017.06.011_bb0025","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00415-005-0918-5","article-title":"Psychotic symptoms in Parkinson's disease: from description to etiology","volume":"252","author":"Papapetropoulos","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2017.06.011_bb0030","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa","volume":"342","author":"Rascol","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2017.06.011_bb0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2377-9-23","article-title":"Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study","volume":"9","author":"Ecker","year":"2009","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jns.2017.06.011_bb0040","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archneur.56.5.595","article-title":"Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study","volume":"56","author":"Aarsland","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2017.06.011_bb0045","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1212\/WNL.50.2.515","article-title":"Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations","volume":"50","author":"Goetz","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2017.06.011_bb0050","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/WNL.0b013e3181f61311","article-title":"What predicts mortality in Parkinson disease?: a prospective population-based long-term study","volume":"75","author":"Forsaa","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2017.06.011_bb0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/S1092852900017296","article-title":"Course, prognosis, and management of psychosis in Parkinson's disease: are current treatments really effective?","volume":"13","author":"Zahodne","year":"2008","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jns.2017.06.011_bb0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.parkreldis.2007.05.009","article-title":"A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementia","volume":"14","author":"McKinlay","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0065","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/mds.25383","article-title":"How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale","volume":"28","author":"Stebbins","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0070","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/ane.12461","article-title":"Non-motor symptoms and quality of life in tremor dominant vs postural instability gait disorder Parkinson's disease patients","volume":"133","author":"Wu","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2017.06.011_bb0075","first-page":"1","article-title":"Parkinson disease: the relationship between non-motor symptoms and motor phenotype","author":"Ba","year":"2015","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.jns.2017.06.011_bb0080","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/mds.20897","article-title":"Changes in motor subtype and risk for incident dementia in Parkinson's disease","volume":"21","author":"Alves","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0085","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/mds.10455","article-title":"Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: a cross-sectional comparative study","volume":"18","author":"Burn","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2015.11.018","article-title":"Interactions of visual hallucinations, rapid eye movement sleep behavior disorder and cognitive impairment in Parkinson's disease: a review","volume":"22","author":"Lenka","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0095","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.nbd.2011.10.003","article-title":"REM sleep behavior disorder: from dreams to neurodegeneration","volume":"46","author":"Postuma","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jns.2017.06.011_bb0100","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1176\/ajp.135.6.669","article-title":"Levodopa-induced psychosis: a kindling phenomenon","volume":"135","author":"Moskovitz","year":"1978","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jns.2017.06.011_bb0105","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.0000000000000842","article-title":"Predictors of dementia in Parkinson disease: a prospective cohort study","volume":"83","author":"Anang","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2017.06.011_bb0110","doi-asserted-by":"crossref","DOI":"10.3233\/JPD-160925","article-title":"Dementia predictors in Parkinson disease: a validation study","author":"Anang","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jns.2017.06.011_bb0115","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/mds.20719","article-title":"REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson's disease","volume":"21","author":"Sinforiani","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0120","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/00023210-200620060-00004","article-title":"Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options","volume":"20","author":"Williams-Gray","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jns.2017.06.011_bb0125","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1212\/WNL.0b013e3181bf992f","article-title":"Incidence of and risk factors for cognitive impairment in an early parkinson disease clinical trial cohort","volume":"73","author":"Uc","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2017.06.011_bb0130","first-page":"1814","article-title":"Pattern of cognitive impairment in patients with Parkinson's disease and psychosis: a critical review","volume":"26","author":"Lenka","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0135","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jns.2014.10.033","article-title":"Cognitive correlates of hallucinations and delusions in Parkinson's disease","volume":"347","author":"Factor","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2017.06.011_bb0140","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.parkreldis.2013.04.026","article-title":"Cognitive correlates of visual hallucinations in non-demented Parkinson's disease patients","volume":"19","author":"Hepp","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0145","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/mds.23525","article-title":"Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease","volume":"26","author":"Bronnick","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/01.WNL.0000101726.69701.FA","article-title":"Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD): does the idiopathic form of RBD really exist?","volume":"62","author":"Ferini-Strambi","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2017.06.011_bb0155","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1212\/01.wnl.0000180964.60708.c2","article-title":"Verbal and visuospatial deficits in dementia with Lewy bodies","volume":"65","author":"Johnson","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2017.06.011_bb0160","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1037\/a0012949","article-title":"Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies","volume":"22","author":"Hamilton","year":"2008","journal-title":"Neuropsychology"},{"key":"10.1016\/j.jns.2017.06.011_bb0165","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/0891988716686830","article-title":"Retrospective neuropsychological profile of patients with Parkinson disease prior to developing visual hallucinations","volume":"30","author":"Muller","year":"2017","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.jns.2017.06.011_bb0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.26432","article-title":"Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase","volume":"31","author":"Pagonabarraga","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0175","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archneur.63.5.713","article-title":"The malignant course of \u201cbenign hallucinations\u201d in Parkinson disease","volume":"63","author":"Goetz","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2017.06.011_bb0180","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/mds.22132","article-title":"Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: positive impact on long-term worsening","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0185","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/jnnp-2016-314832","article-title":"Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative","volume":"88","author":"Ffytche","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2017.06.011_bb0190","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/JGP.0b013e31821f1b41","article-title":"Prevalence of psychotic symptoms in a community-based Parkinson disease sample","volume":"20","author":"Mack","year":"2012","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jns.2017.06.011_bb0195","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/mds.25389","article-title":"Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study","volume":"28","author":"Zhu","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0200","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/mds.23375","article-title":"Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations","volume":"26","author":"Meppelink","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0205","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.parkreldis.2015.04.005","article-title":"Structural and functional neuroimaging in patients with Parkinson's disease and visual hallucinations: a critical review","volume":"21","author":"Lenka","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0210","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/brain\/awt360","article-title":"Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations","volume":"137","author":"Goldman","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.jns.2017.06.011_bb0215","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1093\/brain\/awr225","article-title":"Testing an aetiological model of visual hallucinations in Parkinson's disease","volume":"134","author":"Gallagher","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.jns.2017.06.011_bb0220","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.parkreldis.2008.05.007","article-title":"Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease","volume":"15","author":"Kalaitzakis","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0225","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.cub.2010.06.068","article-title":"The hippocampus plays a selective role in the retrieval of detailed contextual memories","volume":"20","author":"Wiltgen","year":"2010","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jns.2017.06.011_bb0230","article-title":"Multimodal MRI of the hippocampus in Parkinson's disease with visual hallucinations","author":"Yao","year":"2014","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.jns.2017.06.011_bb0235","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2012-303391","article-title":"Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson\u2019s disease","author":"Shin","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2017.06.011_bb0240","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00415-011-6149-z","article-title":"The pedunculopontine nucleus is related to visual hallucinations in Parkinson's disease: preliminary results of a voxel-based morphometry study","volume":"259","author":"Janzen","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2017.06.011_bb0245","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1093\/brain\/awp166","article-title":"Functional involvement of central cholinergic circuits and visual hallucinations in Parkinsons disease","volume":"132","author":"Manganelli","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.jns.2017.06.011_bb0250","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1471-2377-13-145","article-title":"Trigger medications and patient-related risk factors for Parkinson disease psychosis requiring anti-psychotic drugs: a retrospective cohort study","volume":"13","author":"Sawada","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jns.2017.06.011_bb0255","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/mds.1204","article-title":"Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open trial","volume":"16","author":"Reading","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2013.00031","article-title":"A hitchhiker's guide to diffusion tensor imaging","author":"Soares","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jns.2017.06.011_bb0265","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/mds.26533","article-title":"Lateral geniculate atrophy in Parkinson's with visual hallucination: a trans-synaptic degeneration?","volume":"31","author":"Lee","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0270","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/mds.22258","article-title":"Brain response to complex visual stimuli in Parkinson's patients with hallucinations: a functional magnetic resonance imaging study","volume":"23","author":"Ram\u00edrez-Ruiz","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0275","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1176\/jnp.2006.18.3.402","article-title":"Preliminary FMRI evidence of visual system dysfunction in Parkinson's disease patients with visual hallucinations","volume":"18","author":"Holroyd","year":"2006","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jns.2017.06.011_bb0280","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1212\/01.WNL.0000141853.27081.BD","article-title":"Altered cortical visual processing in PD with hallucinations: an fMRI study","volume":"63","author":"Stebbins","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2017.06.011_bb0285","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mds.24900","article-title":"Investigating visual misperceptions in Parkinson's disease: a novel behavioral paradigm","volume":"27","author":"Shine","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0290","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1002\/hbm.22321","article-title":"The role of dysfunctional attentional control networks in visual misperceptions in Parkinson's disease","volume":"35","author":"Shine","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.jns.2017.06.011_bb0295","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00702-016-1528-3","article-title":"Dysfunction in attentional processing in patients with Parkinson's disease and visual hallucinations","volume":"123","author":"Hall","year":"2016","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jns.2017.06.011_bb0300","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/mds.23896","article-title":"Visual misperceptions and hallucinations in Parkinson's disease: dysfunction of attentional control networks?","volume":"26","author":"Shine","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0305","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pneurobio.2014.01.004","article-title":"Tricks of the mind: visual hallucinations as disorders of attention","volume":"116","author":"Shine","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jns.2017.06.011_bb0310","doi-asserted-by":"crossref","first-page":"128ra41","DOI":"10.1126\/scitranslmed.3003391","article-title":"Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts","volume":"4","author":"Politis","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jns.2017.06.011_bb0315","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnsys.2011.00031","article-title":"Noradrenaline and Parkinson's disease","volume":"5","author":"Delaville","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.jns.2017.06.011_bb0320","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1017\/S1092852916000602","article-title":"Parkinson's disease psychosis as a serotonin-dopamine imbalance syndrome","volume":"21","author":"Stahl","year":"2016","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jns.2017.06.011_bb0325","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jns.2016.03.005","article-title":"Genetic substrates of psychosis in patients with Parkinson's disease: a critical review","volume":"364","author":"Lenka","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2017.06.011_bb0330","first-page":"226","article-title":"The apolipoprotein E epsilon 4 allele increases the risk of drug-induced hallucinations in Parkinson's disease","volume":"22","author":"de la Fuente-Fern\u00e1ndez","year":"1993","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jns.2017.06.011_bb0335","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00008571-200306000-00008","article-title":"Cholecystokinin, cholecystokinin-a receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease","volume":"13","author":"Wang","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jns.2017.06.011_bb0340","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archneur.61.8.1280","article-title":"Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system","volume":"61","author":"Goldman","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2017.06.011_bb0345","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1034\/j.1399-0004.1999.560508.x","article-title":"Association between polymorphism of the cholecystokinin gene and idiopathic Parkinson's disease","volume":"56","author":"Fujii","year":"1999","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jns.2017.06.011_bb0350","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/mds.23655","article-title":"Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations","volume":"26","author":"Goldman","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0355","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1523\/JNEUROSCI.05-08-01972.1985","article-title":"Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence","volume":"5","author":"Crawley","year":"1985","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2017.06.011_bb0360","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JPD-150686","article-title":"Oculo-visual dysfunction in Parkinson's disease","volume":"5","author":"Armstrong","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jns.2017.06.011_bb0365","first-page":"2473","article-title":"Decreased dopamine in the retinas of patients with Parkinson's disease","volume":"31","author":"Harnois","year":"1990","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jns.2017.06.011_bb0370","doi-asserted-by":"crossref","first-page":"e34891","DOI":"10.1371\/journal.pone.0034891","article-title":"Optical coherence tomography in parkinsonian syndromes","volume":"7","author":"Albrecht","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2017.06.011_bb0375","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3233\/JPD-130306","article-title":"Optical coherence tomography in Parkinson's disease: is the retina a biomarker?","volume":"4","author":"Lee","year":"2014","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jns.2017.06.011_bb0380","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.parkreldis.2015.08.002","article-title":"Optical coherence tomography as a tool to evaluate retinal changes in Parkinson's disease","volume":"21","author":"Mailankody","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0385","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mds.25543","article-title":"Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's disease","volume":"29","author":"Lee","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0390","article-title":"Changes of retina are not involved in the genesis of visual hallucinations in Parkinson's disease","volume":"2015","author":"Kopal","year":"2015","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.jns.2017.06.011_bb0395","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/mds.21382","article-title":"Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH Work Group","volume":"22","author":"Ravina","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0400","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2017.06.011_bb0405","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/mds.26522","article-title":"Accuracy of screening instruments for detection of neuropsychiatric syndromes in Parkinson's disease","volume":"31","author":"Martinez-Martin","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0410","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1212\/WNL.57.11.2078","article-title":"Prospective longitudinal assessment of hallucinations in Parkinson's disease","volume":"57","author":"Goetz","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2017.06.011_bb0415","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s00415-005-0816-x","article-title":"Development and evaluation of the Parkinson Psychosis Questionnaire A screening-instrument for the early diagnosis of drug-induced psychosis in Parkinson's disease","volume":"252","author":"Brandstaedter","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2017.06.011_bb0420","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.parkreldis.2012.10.022","article-title":"Performance of a shortened Scale for Assessment of Positive Symptoms for Parkinson's disease psychosis","volume":"19","author":"Voss","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0425","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40734-015-0024-5","article-title":"A novel scale to assess psychosis in patients with parkinson's disease","volume":"2","author":"Ondo","year":"2015","journal-title":"J. Clin. Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0430","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/mdc3.12139","article-title":"Validation of the psychosis and hallucinations questionnaire in non-demented patients with Parkinson's disease","volume":"2","author":"Shine","year":"2015","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.jns.2017.06.011_bb0435","doi-asserted-by":"crossref","first-page":"0245","DOI":"10.1371\/journal.pcbi.0010042","article-title":"The human connectome: a structural description of the human brain","volume":"1","author":"Sporns","year":"2005","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jns.2017.06.011_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YCO.0000000000000157","article-title":"Connectome and schizophrenia","volume":"28","author":"Narr","year":"2015","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.jns.2017.06.011_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13229-015-0058-4","article-title":"Abnormal wiring of the connectome in adults with high-functioning autism spectrum disorder","volume":"6","author":"Roine","year":"2015","journal-title":"Mol. Autism"},{"key":"10.1016\/j.jns.2017.06.011_bb0450","first-page":"2696","article-title":"Connectome and maturation profiles of the developing mouse brain using diffusion tensor imaging","author":"Ingalhalikar","year":"2014","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.jns.2017.06.011_bb0455","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1073\/pnas.1316909110","article-title":"Sex differences in the structural connectome of the human brain","volume":"111","author":"Ingalhalikar","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2017.06.011_bb0460","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.neurobiolaging.2014.01.001","article-title":"Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies","volume":"35","author":"Graff-Radford","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2017.06.011_bb0465","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1552-6569.2007.00203.x","article-title":"Proton magnetic resonance spectroscopy detects a relative decrease of N-acetylaspartate in the hippocampus of patients with dementia with Lewy bodies","volume":"18","author":"Xuan","year":"2008","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.jns.2017.06.011_bb0470","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/mds.25104","article-title":"Anterior cingulate integrity: executive and neuropsychiatric features in Parkinson's disease","volume":"27","author":"Lewis","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0475","first-page":"227","article-title":"Proton magnetic resonance spectroscopy changes in Parkinson's disease with and without psychosis","volume":"67","author":"Rodriguez-Violante","year":"2015","journal-title":"Rev. Investig. Clin."},{"key":"10.1016\/j.jns.2017.06.011_bb0480","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fncel.2015.00025","article-title":"Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases","volume":"9","author":"Gardoni","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jns.2017.06.011_bb0485","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1196\/annals.1300.004","article-title":"Electrophysiological interactions between striatal glutamatergic and dopaminergic systems","author":"West","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jns.2017.06.011_bb0490","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/mds.25846","article-title":"What can biomarkers tell us about cognition in Parkinson's disease?","volume":"29","author":"Mollenhauer","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0495","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/mds.25213","article-title":"\u03b2-amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia","volume":"28","author":"M\u00fcller","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.06.011_bb0500","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jns.2017.06.011_bb0505","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2017.06.011_bb0510","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuroscience.2015.05.018","article-title":"The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders","volume":"300","author":"R\u00e9us","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2017.06.011_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-10-43","article-title":"Neuroinflammation and psychiatric illness","volume":"10","author":"Najjar","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2017.06.011_bb0520","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085886","article-title":"Subclinical elevation of plasma C-reactive protein and illusions\/hallucinations in subjects with Parkinson's disease: case-control study","volume":"9","author":"Sawada","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2017.06.011_bb0525","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047387","article-title":"Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serum","volume":"7","author":"Lindqvist","year":"2012","journal-title":"PLoS One"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17303854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17303854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T12:58:36Z","timestamp":1750337916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X17303854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":105,"alternative-id":["S0022510X17303854"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2017.06.011","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychosis in Parkinson's disease: From the soft signs to the hard science","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2017.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}